FDA Special Session: Subgroups and Subpopulations in HF Clinical Trials

This session aims to discuss definitions and phenotyping of subgroups in HF trials, how to define specialized subsets of HF, and principles for identifying appropriate analysis and endpoints in HF trial subgroups and subsets. Additionally, the HFC-HFSA site based research awardees will be recognized. This is the official FDA designated special focus session.